Account management for Central Virginia

Lineagen offers FirstStepDx PLUS a customized genetic testing service for individuals with autism spectrum disorder (ASD) and other disorders of childhood development plus a portfolio of scientific programs in ASD.In conditions such as ASD, critical time, sometimes years, can be lost during the diagnostic odyssey, which spans earliest concern to clinical action. Lineagen's mission is to accelerate and enhance the diagnostic evaluation of medical conditions so that the best possible outcomes can be achieved for patients and their families. At Lineagen we firmly believe that we can change this for the better. Access to recommended genetic testing for individuals with autism and developmental delay should have no waiting list since it is available today - we believe that genetics can provide healthcare professionals with timely and objective information to aid in the clinical diagnostic evaluation of children with ASD or other forms of developmental delay. And we believe that personalized counseling will help patients, as well as their physicians, to make better and more informed decisions.

The ForeCYTE Breast Health test from Atossa Genetics is a cutting edge approach towards significantly reducing breast cancer. The test utilizes a hand held, 510k cleared modified breast pump, to sample nipple aspirate fluid (NAF) from the breast duct system where approximately 85% of breast cancers arise. Think of this as a Pap smear for the breast.Noninvastive, painless, and takes less than 10 minutesAdministered by nurseCan be used on patients ages 18-7398% NAF collection success rate (exceeds 50% success rate of ealrier ductal fluid collection systems)Provides vital early detection up to 8 years before visible tumorsCovered by insuranceView video at http://vimeo.com/62214008

•Disease States: Lung Cancer, Colorectal Cancer, Melanoma Cancer and Gastric CancerResponse Genetics developed and marketed PCR-based genetics tests—ResponseDX: Lung™, ResponseDX: Colon™, ResponseDX: Gastric™, ResponseDX: Melanoma™——to help physicians with therapeutic treatment decisions for patients with non-small cell lung cancer (NSCLC) ERCC1, EGFR, EML4-ALK, colorectal cancer (CRC) KRAS, BRAF, NRAS, PI3, MSI, ERCC1, EGFR, TS, gastric cancer HER2 and Melanoma (BRAF). Response Genetics, Inc. (“RGI”) (NASDAQ:RGDX) engaged in the research and development of pharmacogenomic cancer diagnostic tests based on its proprietary and patented technologies which enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin embedded specimens *Related Lung, Colon, Gastric, and Melanoma Agents/Knowledge: Erlotinib (Tarceva), Pemetrexed (Alimta), Cetuximab (Erbitux), Avastin, Carboplatin, Cisplatin, FOLFOX, Oxaliplatin, FOLFIRI, IRI- Irinotecan, Gemcitabine, XALKORI® (crizotinib), zelboraf (vemurafenib)

Ranked 1 out of 93 based on portfolio earnings for Aloxi, Dacogen and Fragmin.

Charter member of 35 representative sales force responsible for promotion of oncology and rheumatology products including Aloxi, Salagen, Dacogen, Mylocel and Hexalen.Worked on various advisory teams to develop standards for sales performance evaluation, incentive compensation, award/recognition, data analysis and sales force automation.(Purchased by Eisai, Inc. February 2008.)

created by acquisition of HMR by RPR; Charter member of the Oncology/Rheumatology Specialty Sales Division ofHoechst Marion Rousell.Relocated from NJ to establish an Oncology/Rheumatology presence for HMRin the Central Virginia marketplace.Successfully launched/promoted Anzemet, Taxotere and Mylocel to MedicalOncologists and Hematologists. Launched/promoted Arava to Rheumatologists. Launched/promoted Nilandron to Urologists

Responsible for promotion of all product lines to major teaching hospitals in the Southern New Jersey and Delaware geographies.Customers included: internists; cardiologists; gastroenterologists; allergists;pharmacists; residents; and ICU/CCU and Emergency Room nurses.

Successfully marketed Priolsec and Carafate to Primary Care; Internal Medicine and GI specialists.Promoted Cardizem and Cardizem Injectable to the cardiovascular marketplace in Southern New Jersey.